SKI Market

Indian Indices

Nifty

24,579.60 -45.45
(-0.18%)

Sensex

80,157.88 -206.61
( -0.26%)

Bank Nifty

53,661.00 -341.45
( -0.63%)

Nifty IT

35,737.90 -2.75
( -0.01%)

Global Indices

Nasdaq

45,565.88 -92.03
(-0.20%)

Dow Jones

6,481.26 -41.60
(-0.64%)

Hang Seng

42,288.11 99.32
(0.24%)

Nikkei 225

9,116.69 -79.65
(-0.87%)

Forex

USD-INR

88.15 0.55
(0.63%)

EUR-INR

103.00 0.84
(0.82%)

GBP-INR

118.99 0.66
(0.55%)

JPY-INR

0.60 0.00
(0.61%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

ANG Lifesciences India Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

540694

INE236W01016

51.1616011

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

33.56

EPS(TTM)

Face Value()

Div & Yield %

Back

Thirumalai Chemicals reports standalone net loss of Rs 13.83 crore in the June 2025 quarter

Aug 15,2025

Net loss of Thirumalai Chemicals reported to Rs 13.83 crore in the quarter ended June 2025 as against net profit of Rs 28.14 crore during the previous quarter ended June 2024. Sales declined 16.52% to Rs 445.50 crore in the quarter ended June 2025 as against Rs 533.64 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	445.50	533.64	-17
OPM %	-0.05	9.47	-
PBDT	-9.58	46.56	PL
PBT	-18.18	38.08	PL
NP	-13.83	28.14	PL

24,579.60 -45.45 (-0.18%)

80,157.88 -206.61 ( -0.26%)

53,661.00 -341.45 ( -0.63%)

35,737.90 -2.75 ( -0.01%)

45,565.88 -92.03 (-0.20%)

6,481.26 -41.60 (-0.64%)

42,288.11 99.32 (0.24%)

9,116.69 -79.65 (-0.87%)

88.15 0.55 (0.63%)

103.00 0.84 (0.82%)

118.99 0.66 (0.55%)

0.60 0.00 (0.61%)